Answer
Imlunestrant should not be used during pregnancy because its mechanism of action and animal embryofoetal toxicity findings indicate it can harm the foetus, with a potential risk of miscarriage; there are no data on its use in pregnant women.
Sources for this answer
- Inluriyo 200 mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked